EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 84 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,511,385 | -5.7% | 1,440,724 | +2.7% | 0.00% | – |
| Q2 2023 | $12,208,171 | +196.8% | 1,403,238 | +0.3% | 0.00% | – |
| Q1 2023 | $4,113,157 | -15.8% | 1,399,033 | +0.2% | 0.00% | – |
| Q4 2022 | $4,884,552 | -55.8% | 1,395,586 | -0.2% | 0.00% | – |
| Q3 2022 | $11,061,000 | +3.7% | 1,398,488 | +3.2% | 0.00% | – |
| Q2 2022 | $10,666,000 | -28.8% | 1,355,318 | +9.9% | 0.00% | – |
| Q1 2022 | $14,979,000 | +2.9% | 1,232,801 | +3.7% | 0.00% | – |
| Q4 2021 | $14,553,000 | +27.9% | 1,188,970 | +8.8% | 0.00% | – |
| Q3 2021 | $11,382,000 | +16.5% | 1,092,306 | +0.6% | 0.00% | – |
| Q2 2021 | $9,766,000 | +6.3% | 1,086,329 | +20.1% | 0.00% | – |
| Q1 2021 | $9,190,000 | +334.1% | 904,439 | +181.1% | 0.00% | – |
| Q4 2020 | $2,117,000 | – | 321,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $36,461,013 | 27.59% |
| ACUTA CAPITAL PARTNERS, LLC | 382,000 | $3,323,400 | 2.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,423,897 | $29,787,904 | 1.59% |
| Cormorant Asset Management, LP | 3,200,000 | $27,840,000 | 1.56% |
| Caligan Partners LP | 310,298 | $2,699,593 | 1.52% |
| Samsara BioCapital, LLC | 432,000 | $3,758,400 | 0.66% |
| RA Capital Management | 3,370,506 | $29,323,402 | 0.55% |
| SECTORAL ASSET MANAGEMENT INC | 311,277 | $2,708,110 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 209,949 | $1,826,556 | 0.26% |
| BARD ASSOCIATES INC | 30,674 | $266,864 | 0.10% |